Latest News

HIV care system deterioration from administrative obstruction and funding delays presages catastrophic effects of potential budget cuts.

Clade I mpox emergence reveals structural collapse in U.S. disease surveillance and public health response infrastructure.

Deteriorating healthcare infrastructure and provider shortages exacerbate rising rates of sexually transmitted infections.

Caregiving infrastructure supports health equity and healthcare outcomes, requiring policy investment in caregiving infrastructure.

Deteriorating public health surveillance capacity creates blind spots for emerging disease threats and health disparities.

Elimination of surveillance funding creates blind spots in disease tracking and health equity measurement.

2022-2023 respiratory season tracking flu, COVID-19, and RSV with severe early indicators.

Louisiana and Washington HCV subscription models save millions but fail elimination goals; cost alone isn't the barrier.

Health misinformation undermines vaccine confidence, perpetuates stigma, and drives poor policy decisions.

STI and HCV rates rise despite reduced screening, reflecting chronic public health underfunding.

Flurona co-infections highlight information challenges amid pandemic fatigue and misinformation.

FDA reclassifies HCV testing to reduce regulatory burden and enable new test makers to enter market.

Global Fund report shows COVID-19 reduced HIV/HCV program efficacy while South Africa tripled ART coverage.

Study explores social-spatial networks and HIV/HCV diagnosis rates among homeless and injection drug users.

Stagnant CMS reimbursement rates since 2016 threaten addiction treatment provider closures and service access.

COVID-19 disrupts STI surveillance as staff redeployment, testing shortages, and clinic closures create gaps.

HHS releases integrated Viral Hepatitis National Strategic Plan calling for a syndemic approach with HIV and STI.

COVID-19 caused a 50% drop in hospital HCV screening and 72% drop in primary care settings.